Search

Your search keyword '"Patel, Preya"' showing total 226 results

Search Constraints

Start Over You searched for: Author "Patel, Preya" Remove constraint Author: "Patel, Preya"
226 results on '"Patel, Preya"'

Search Results

1. Bilateral Cranial Nerve VI Palsies in Cryptococcal Meningitis, HIV, and Syphilis: A Case Report

5. Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores

12. SURVIVING CANCER BUT SUCCUMBING TO COVID-19 PNEUMONIA: A STUDY OF FEBRILE NEUTROPENIA PATIENTS

16. SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE: INVESTIGATING THE ROLE OF HEART FAILURE THROUGH NATIONAL READMISSION DATA

26. Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary–secondary care interface

27. Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply.

28. Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply.

29. Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma

34. Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

35. Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.

37. COVID-19 and liver cancer: lost patients and larger tumours

39. Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD.

40. Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients.

41. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation

42. Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety

44. Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests

46. PWE-43 SARS-CoV-2 one year on – the worrying impact on early detection of liver cancers

48. Additional file 3 of The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study

49. Additional file 1 of The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study

50. Additional file 2 of The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study

Catalog

Books, media, physical & digital resources